Literature DB >> 8509170

Liver transplantation for fulminant hepatic failure.

S D Lidofsky1.   

Abstract

In conclusion, the availability of liver transplantation has dramatically advanced the management of fulminant hepatic failure. A major responsibility of the gastroenterologist/hepatologist involved in the care of patients with liver failure is early decision making regarding likelihood of spontaneous recovery and consideration toward referral to a transplantation center. In particular, patients with exposure to drugs or toxins (other than acetaminophen); patients with presumed non-A, non-B hepatitis; children or older patients; patients with prolonged jaundice; profoundly jaundiced patients; or patients with severe coagulopathy should be given the highest consideration for urgent transplantation. Supportive care should take into account the potential complications of bleeding, sepsis, cerebral edema, renal failure, and respiratory failure. Such complications are the major limiting factors that prevent patients with fulminant hepatic failure from undergoing liver transplantation and contribute to the majority of postoperative deaths among patients who undergo transplantation. If these issues are heeded, and in light of emerging therapeutic modalities and surgical innovations, it is anticipated that ongoing improvement of the overall outcome of patients with fulminant hepatic failure will continue to be seen.

Entities:  

Mesh:

Year:  1993        PMID: 8509170

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  12 in total

Review 1.  Liver transplantation in the UK.

Authors:  S R Bramhall; E Minford; B Gunson; J A Buckels
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube.

Authors:  Dmitry Frank; Shiri Savir; Benjamin F Gruenbaum; Israel Melamed; Julia Grinshpun; Ruslan Kuts; Boris Knyazer; Alexander Zlotnik; Max Vinokur; Matthew Boyko
Journal:  J Vis Exp       Date:  2020-04-28       Impact factor: 1.355

3.  Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats.

Authors:  Benjamin Fredrick Gruenbaum; Matthew Boyko; Bertha Delgado; Amos Douvdevany; Shaun Evan Gruenbaum; Israel Melamed; Micky Gideon; Evaldas Cesnulis; Yoram Shapira; Alexander Zlotnik
Journal:  Hepatol Int       Date:  2012-11-22       Impact factor: 6.047

4.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

5.  Fulminant hepatic failure (FHF) due to acute hepatitis C.

Authors:  Bilal Bin Younis; Rozina Arshad; Saima Khurhsid; Junaid Masood; Farhan Nazir; Maham Tahira
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

6.  Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report.

Authors:  Harsha Moole; Zohair Ahmed; Nibha Saxena; Srinivas R Puli; Sonu Dhillon
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-10-19

7.  Acute Hepatitis B with Pancreatitis and Cholecystitis Leading to Acute Liver Failure and Death.

Authors:  Andrew R Albert; Ronald Valencia; Janet A Smereck
Journal:  Clin Pract Cases Emerg Med       Date:  2018-08-15

8.  Fulminate hepatic failure as an initial presentation of non-hodgkin lymphoma: a case report.

Authors:  Bizhan Ahmadi; Sara Shafieipour; Kambiz Akhavan Rezayat
Journal:  Middle East J Dig Dis       Date:  2014-04

Review 9.  [Acute liver failure].

Authors:  Karoline Rutter; Thomas Horvatits; Andreas Drolz; Kevin Roedl; Stephanie Siedler; Stefan Kluge; Valentin Fuhrmann
Journal:  Wien Klin Mag       Date:  2018-09-06

10.  [Acute liver failure].

Authors:  A Koch; C Trautwein
Journal:  Intensivmed Notfallmed       Date:  2010-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.